high MI: The Impact of High Mechanical Index Ultrasound Impulses on Left Ventricular Stroke Volume in Patients Receiving Intravenous Microbubbles

Sponsor
University of Nebraska (Other)
Overall Status
Withdrawn
CT.gov ID
NCT05700032
Collaborator
(none)
0
2
12

Study Details

Study Description

Brief Summary

The purpose of this study is to investigate whether applying high MI impulses from a diagnostic ultrasound transducer when using ultrasound enhancing agent(UEA) microbubble infusion will result in subclinical improvement in LV systolic function detected by LVOT VTI.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: high MI impulses
  • Diagnostic Test: low MI impulses
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
The Impact of High Mechanical Index Ultrasound Impulses on Left Ventricular Stroke Volume in Patients Receiving Intravenous Microbubbles
Anticipated Study Start Date :
Aug 1, 2020
Anticipated Primary Completion Date :
Aug 1, 2021
Anticipated Study Completion Date :
Aug 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: high MI

patients receiving high MI impulses

Diagnostic Test: high MI impulses
patients will receive intermittent high MI impulses(>1.0) in addition to low MI imaging. LVOT VTI will be measured at different times per protocol.

Active Comparator: low MI

patients receiving low MI impulses

Diagnostic Test: low MI impulses
patients will receive low MI imaging only. LVOT VTI will be measured at different times per protocol.

Outcome Measures

Primary Outcome Measures

  1. LVOT VTI [10 minutes]

Secondary Outcome Measures

  1. stroke volume [10 minutes]

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

age 19 years or older

Exclusion Criteria:
  1. severe aortic valve stenosis

  2. pregnant or lactating women

  3. atrial fibrillation

  4. very poor image quality despite contrast use.

  5. unstable cardiac condition such as cardiogenic shock.

  6. allergy to UEA

  7. presence of right to left or bidirectional shunts.

  8. Patients on mechanical circulatory support.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Nebraska

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Nebraska
ClinicalTrials.gov Identifier:
NCT05700032
Other Study ID Numbers:
  • 134-20-FB
First Posted:
Jan 26, 2023
Last Update Posted:
Jan 26, 2023
Last Verified:
Jan 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 26, 2023